These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1755709)

  • 21. [Study of the effectiveness of new quaternary ammonium salts against selected strains of bacteria and fungi. Sensitivity of microbial strains isolated from patients to various ammonium salts].
    Pernak J; Kucharski S
    Acta Pol Pharm; 1979; 36(3):377-82. PubMed ID: 117676
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro activity of several antimicrobial agents against selected clinical isolates.
    Liebowitz LD; Saunders J; Chalkley LJ; Koornhof HJ
    S Afr Med J; 1990 Apr; 77(8):395-400. PubMed ID: 2109875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of aerobic microorganisms isolated from intraabdominal infections in pediatric patients in Poland.
    Dzierzanowska-Fangrat K; Semczuk K; Łopaciuk U; Kurlenda J; Małafiej E; Puacz E; Stalmaska-Dworak E; Dzierzanowska D
    Med Sci Monit; 2005 May; 11(5):CR241-245. PubMed ID: 15874890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A contribution to the situation of antibiotic resistance in Abeokuta (Ogunstate) and Minna (Nigerstate) in Nigeria.
    Sixl W; Sixl-Voigt B; Schneeweiss WD; Schuhmann G; Rosegger H
    Geogr Med Suppl; 1989; 5():145-52. PubMed ID: 2599386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The extent of resistance on clinically important pathogens in the Federal Republic].
    Pulverer G
    Adv Clin Pharmacol; 1974; 8():21-32. PubMed ID: 4157112
    [No Abstract]   [Full Text] [Related]  

  • 29. [In vitro bacteriostatic activity of piperacillin sodium against Pseudomonas].
    de Nóbile VB; Nóbile C; Puertas MJ
    Rev Argent Microbiol; 1986; 18(1):45-8. PubMed ID: 3685380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity of cephamandole--a new antibiotic.
    Goyal P; Bhatia R; Baveja UK; Agarwal DS
    J Commun Dis; 1982 Jun; 14(2):130-3. PubMed ID: 6818272
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic susceptibility of bacteria isolated from active, therapy-resistant periodontal sites.
    De Luca M
    Chemioterapia; 1988 Oct; 7(5):309-12. PubMed ID: 3147149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibacterial activity in vitro of a new rifamycin: rifamide].
    Monnier J; Bourse R
    Pathol Biol; 1968 Oct; 16(19):901-8. PubMed ID: 4972879
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacodynamics of piperacillin in severely ill patients evaluated by using a PK/PD model.
    Sauermann R; Zeitlinger M; Erovic BM; Marsik C; Georgopoulos A; Müller M; Brunner M; Joukhadar C
    Int J Antimicrob Agents; 2003 Dec; 22(6):574-8. PubMed ID: 14659654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disulfiram inhibits the in vitro growth of methicillin-resistant staphylococcus aureus.
    Phillips M; Malloy G; Nedunchezian D; Lukrec A; Howard RG
    Antimicrob Agents Chemother; 1991 Apr; 35(4):785-7. PubMed ID: 2069390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An assessment of the Sensititre method for determining minimum inhibitory and bactericidal concentrations.
    Pykett AH
    J Clin Pathol; 1978 Jun; 31(6):536-8. PubMed ID: 670408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeat antimicrobial susceptibility testing of identical isolates.
    Thomson RB; File TM; Burgoon RA
    J Clin Microbiol; 1989 May; 27(5):1108-11. PubMed ID: 2501342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a rapid inoculum standardization system for antimicrobial susceptibility testing of bacterial isolates from the bovine mammary gland.
    Watts JL; Nickerson SC
    Vet Microbiol; 1986 Sep; 12(3):269-76. PubMed ID: 3535234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antibacterial activity of a novel biphenyl-ureido penicillin.
    Driver MJ; Lowther J
    J Antibiot (Tokyo); 1986 Oct; 39(10):1502-4. PubMed ID: 3096926
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative antibacterial activity of Vancocin and generic vancomycin.
    Conte JE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):333-4. PubMed ID: 3566255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enzymatic lysis of staphylococci in relation to their species and strain properties].
    Babenko IuS; Ghilomedova LE; Kukushkina NV
    Antibiot Khimioter; 1990 Mar; 35(3):20-2. PubMed ID: 2360850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.